February 2020
A study on the disclosure of the results of clinical trials found that a majority did not meet the publication deadline, with non-industry most likely to fail to publish:
Leveraging Eurofins’ pharmacology, in-vitro models and ADME capabilities, PharmaResources aims to accelerate drug discovery for its clients in small molecule drug R&D:
SCORR Marketing, a global health science communications firm, has released a life sciences industry salary and employee satisfaction survey report:
The UK is experiencing a boom in the number of cell and gene therapy clinical trials:
Acquisition of Clindata’s human health biometrics division is expected to increase Synteract’s geographical footprint along with the adaptability of its biometrics services solutions.
